Alafen
| Alafen | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 206.28 g/mol [1] |
| Predicted LogP | 0.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H18N2O |
| IUPAC name | 3-amino-N-(1-phenylpropan-2-yl)propanamide |
| SMILES | CC(CC1=CC=CC=C1)NC(=O)CCN |
| InChI | InChI=1S/C12H18N2O/c1-10(14-12(15)7-8-13)9-11-5-3-2-4-6-11/h2-6,10H,7-9,13H2,1H3,(H,14,15) |
| InChIKey | MITLKXZMISFLMO-UHFFFAOYSA-N |
| PubChem CID | 63010583 |
Alafen (also known as 3-amino-N-(1-phenylpropan-2-yl)propanamide) is a substance of the amphetamine class.
Chemistry
Stereochemistry []
Alafen is a racemic mixture of the enantiomers.
Druglikeness
Lipinski's rule of five
Alafen matches Lipinski's rule of five.See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 63010583, Alafen. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/63010583
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:31:25 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 07:31:21 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:31:21 |
| gsrs | missing (no UNII) | 2026-11-20 07:31:21 |
| hmdb | missing (no HMDB id) | 2026-11-20 07:31:21 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 07:31:23 |
| pubchem | ok | 2026-11-20 07:31:21 |
| missing (no r/tripreports posts mention it) | 2026-11-20 07:31:21 | |
| sider | missing (not in SIDER) | 2026-11-20 07:31:21 |
| structure | ok | 2026-11-20 07:31:21 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 07:31:21 |